Vir Biotechnology OverviewVir Biotechnology Other Income Expense Net
Other Income/Expense Net for VIR.
Quarterly Other Income/Expense
$6.76M
↓ 63.63% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$18.42M
↓ 66.43% YoY
Trailing 12 months ending Mar 31, 2026